Literature DB >> 20364323

The clinical applicability of the Self-Appraisal of Illness Questionnaire (SAIQ) to chronic schizophrenic patients in Taiwan.

Yu-Chen Kao1, Yia-Ping Liu.   

Abstract

Over the last decade, several self-report instruments to assess insight of illness from schizophrenic patients' perspectives have been administered. The main purpose of this study was to ascertain the reliability and validity of the Taiwanese version of the Self-Appraisal of Illness Questionnaire (SAIQ) in a chronic schizophrenic sample in Taiwan. This scale is a self-administered instrument designed to evaluate attitudes toward mental illness among patients receiving treatment. In the current cross-sectional study, 104 patients who met DSM-IV criteria for schizophrenic disorders were recruited and independently interviewed. The psychometric properties of the translated SAIQ were determined, including internal consistency, test-retest reliability, and construct validity. In addition, we analyzed psychosocial and clinical characteristics as correlates of the Taiwanese version of the SAIQ. Overall, the Taiwanese version of the SAIQ was found to be internally consistent and reliable over time. This translated scale comprised a three-factor solution with factors corresponding to worry, the need for treatment, and presence/outcome subscales. The results also indicated that the three subscales and its total score were significantly associated with both the research-rated insight scale and psychopathology and mood state. This culture-specific study shows that the Taiwanese version of the SAIQ is a simple and reliable scale for use.

Entities:  

Mesh:

Year:  2010        PMID: 20364323     DOI: 10.1007/s11126-010-9131-5

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  20 in total

1.  Insight and suicidality in schizophrenia: a replication study.

Authors:  R C Schwartz
Journal:  J Nerv Ment Dis       Date:  2000-04       Impact factor: 2.254

Review 2.  Insight in schizophrenia: a meta-analysis.

Authors:  Alisa R Mintz; Keith S Dobson; David M Romney
Journal:  Schizophr Res       Date:  2003-05-01       Impact factor: 4.939

3.  Insight and illness in chronic schizophrenia.

Authors:  R C Schwartz
Journal:  Compr Psychiatry       Date:  1998 Sep-Oct       Impact factor: 3.735

4.  An inventory for measuring clinical anxiety: psychometric properties.

Authors:  A T Beck; N Epstein; G Brown; R A Steer
Journal:  J Consult Clin Psychol       Date:  1988-12

5.  Lack of insight: its status within schizophrenic psychopathology.

Authors:  V Peralta; M J Cuesta
Journal:  Biol Psychiatry       Date:  1994-10-15       Impact factor: 13.382

Review 6.  Patients' subjective experiences on antipsychotic medications: implications for outcome and quality of life.

Authors:  A G Awad; T P Hogan; L N Voruganti; R J Heslegrave
Journal:  Int Clin Psychopharmacol       Date:  1995-09       Impact factor: 1.659

7.  Insight in schizophrenia. Its relationship to acute psychopathology.

Authors:  J P McEvoy; L J Apperson; P S Appelbaum; P Ortlip; J Brecosky; K Hammill; J L Geller; L Roth
Journal:  J Nerv Ment Dis       Date:  1989-01       Impact factor: 2.254

8.  Quality of life as an evaluative measure in assessing the impact of community care on people with long-term psychiatric disorders.

Authors:  M M Barry; C Crosby
Journal:  Br J Psychiatry       Date:  1996-02       Impact factor: 9.319

9.  A comparison between an interview and a self-report method of insight assessment in chronic schizophrenia.

Authors:  Donald A Young; Zachariah Campbell; Konstantine K Zakzanis; Earl Weinstein
Journal:  Schizophr Res       Date:  2003-09-01       Impact factor: 4.939

10.  [Insight in schizophrenia: assessment of 31 patients with different scales].

Authors:  D Travers; D Levoyer; B Millet
Journal:  Encephale       Date:  2007-09-05       Impact factor: 1.291

View more
  5 in total

1.  Suicidal behavior and insight into illness among patients with schizophrenia spectrum disorders.

Authors:  Yu-Chen Kao; Yia-Ping Liu
Journal:  Psychiatr Q       Date:  2011-09

2.  The impact of cognitive insight, self-stigma, and medication compliance on the quality of life in patients with schizophrenia.

Authors:  Yin-Ju Lien; Hsin-An Chang; Yu-Chen Kao; Nian-Sheng Tzeng; Chien-Wen Lu; Ching-Hui Loh
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-07-29       Impact factor: 5.270

3.  Insight, self-stigma and psychosocial outcomes in Schizophrenia: a structural equation modelling approach.

Authors:  Y-J Lien; H-A Chang; Y-C Kao; N-S Tzeng; C-W Lu; C-H Loh
Journal:  Epidemiol Psychiatr Sci       Date:  2016-12-15       Impact factor: 6.892

4.  Assessing cognitive insight in nonpsychiatric individuals and outpatients with schizophrenia in Taiwan: an investigation using the Beck Cognitive Insight Scale.

Authors:  Yu-Chen Kao; Tzong-Shi Wang; Chien-Wen Lu; Yia-Ping Liu
Journal:  BMC Psychiatry       Date:  2011-10-21       Impact factor: 3.630

5.  The Effects of Bi-Anodal tDCS Over the Prefrontal Cortex Regions With Extracephalic Reference Placement on Insight Levels and Cardio-Respiratory and Autonomic Functions in Schizophrenia Patients and Exploratory Biomarker Analyses for Treatment Response.

Authors:  Chuan-Chia Chang; Yu-Chen Kao; Che-Yi Chao; Nian-Sheng Tzeng; Hsin-An Chang
Journal:  Int J Neuropsychopharmacol       Date:  2021-01-20       Impact factor: 5.176

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.